Skip to main content
. 2019 Jul 16;2019:1534365. doi: 10.1155/2019/1534365

Figure 3.

Figure 3

Funnel plot for the comparison of the incidence of neoplasia with the use of GLP-1 receptor agonists versus placebo or other antidiabetic treatments.